EVFM
Evofem Biosciences Inc

17,918
Mkt Cap
$1.2M
Volume
0.00
52W High
$0.016
52W Low
$0.0061
PE Ratio
-0.15
EVFM Fundamentals
50D MA
$0.0115
Beta
0.08
Avg. Volume
750,485.19
EPS (Annual)
-$0.1192
P/B
-0.02
Rev/Employee
$605,093.75
Loading...
Loading...
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes products to women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
32

Frequently Asked Questions

What is Market Cap of Evofem Biosciences Inc?
What is the 52-week high for Evofem Biosciences Inc?
What is the 52-week low for Evofem Biosciences Inc?
What is the PE ratio of Evofem Biosciences Inc?
What is the Price-to-Book ratio of Evofem Biosciences Inc?
What is the 50-day moving average of Evofem Biosciences Inc?
How many employess does Evofem Biosciences Inc has?

Latest EVFM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.